Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499187 · ClinicalTrials.gov registry record
Fanconi Syndrome Due to ARVs in HIV-Infected Persons
A clinical trial, sponsored by Gilead Sciences.
- Completed
- Registry status
- 56
- Enrollment target
NCT00499187: Completed study, sponsored by Gilead Sciences.
NCT00499187 is a clinical trial that has completed, run by Gilead Sciences. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499187 has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
Cross-sectional cohort study of participants with HIV with or without protocol-defined Fanconi syndrome (confirmed creatinine clearance \[CLcr\] decline and evidence of proximal tubulopathy).
Interventions
- PROCEDURE Blood Draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-03 |
What the finished NCT00499187 record still lists
NCT00499187 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood Draws is the first listed.
NCT00499187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00499187 about?
NCT00499187 is a clinical study titled "Fanconi Syndrome Due to ARVs in HIV-Infected Persons". Cross-sectional cohort study of participants with HIV with or without protocol-defined Fanconi syndrome (confirmed creatinine clearance \[CLcr\] decline and evidence of proximal tubulopathy).
What is the current status of trial NCT00499187?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2007-09. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00499187?
The interventions under investigation include: Blood Draws (PROCEDURE).
Who is sponsoring clinical trial NCT00499187?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia